These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1762429)

  • 1. Smoking cessation and prevention.
    Jones JL
    J S C Med Assoc; 1991 Dec; 87(12):592-3. PubMed ID: 1762429
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
    Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
    Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.
    Thavorn K; Chaiyakunapruk N
    Tob Control; 2008 Jun; 17(3):177-82. PubMed ID: 18285385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Economic evaluation of smoking cessation interventions: have we overlooked something].
    Trapero-Bertran M
    Arch Bronconeumol; 2009 May; 45(5):209-11. PubMed ID: 19395140
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?
    Menzin J; Lines LM; Marton J
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):257-64. PubMed ID: 19527098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of varenicline for smoking cessation.
    Keiding H
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of the Danish smoking cessation interventions: subgroup analysis based on the Danish Smoking Cessation Database.
    Olsen KR; Bilde L; Juhl HH; Kjaer NT; Mosbech H; Evald T; Rasmussen M; Hiladakis H
    Eur J Health Econ; 2006 Dec; 7(4):255-64. PubMed ID: 16816946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression.
    Barnett PG; Wong W; Hall S
    Addiction; 2008 May; 103(5):834-40. PubMed ID: 18412763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation in pregnancy.
    Brown DC
    Can Fam Physician; 1996 Jan; 42():102-5. PubMed ID: 8924801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Workplace smoking cessation].
    Tønnesen H; Møller AM
    Ugeskr Laeger; 2004 Oct; 166(42):3700-2. PubMed ID: 15508289
    [No Abstract]   [Full Text] [Related]  

  • 11. Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
    Bolin K; Mörk AC; Willers S; Lindgren B
    Respir Med; 2008 May; 102(5):699-710. PubMed ID: 18289839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.
    Boyd KA; Briggs AH
    Addiction; 2009 Feb; 104(2):317-25. PubMed ID: 19149829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Practical guides for stopping the tobacco habit: a cost-effectiveness analysis?].
    Pérez Trullén A; Sánchez Agudo L
    Arch Bronconeumol; 1999 May; 35 Suppl 3():89-94. PubMed ID: 10410233
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and cost-effectiveness of a minimal intervention to prevent smoking relapse: dismantling the effects of amount of content versus contact.
    Brandon TH; Meade CD; Herzog TA; Chirikos TN; Webb MS; Cantor AB
    J Consult Clin Psychol; 2004 Oct; 72(5):797-808. PubMed ID: 15482038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits of switching smoking cessation drugs to over-the-counter status.
    Keeler TE; Hu TW; Keith A; Manning R; Marciniak MD; Ong M; Sung HY
    Health Econ; 2002 Jul; 11(5):389-402. PubMed ID: 12112489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-effectiveness of the methods of smoking cessation].
    Plans P; Navas E; Tarín A; Rodríguez G; Galí N; Gayta R; Taberner JL; Salleras L
    Med Clin (Barc); 1995 Jan; 104(2):49-54. PubMed ID: 7869779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling.
    Pinget C; Martin E; Wasserfallen JB; Humair JP; Cornuz J
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):451-5. PubMed ID: 17568248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of a family physician delivered smoking cessation program.
    Buck DJ; Richmond RL; Mendelsohn CP
    Prev Med; 2000 Dec; 31(6):641-8. PubMed ID: 11133329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experts' agreement on the relative effectiveness of 29 smoking reduction strategies.
    Paul CL; Sanson-Fisher RW
    Prev Med; 1996; 25(5):517-26. PubMed ID: 8888319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation.
    Nielsen K; Fiore MC
    Prev Med; 2000 Mar; 30(3):209-16. PubMed ID: 10684744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.